Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis

被引：0

作者：

Sharmin, S. ^{[1
,2
]}

Lefort, M. ^{[3
]}

Andersen, J. ^{[4
]}

Horakova, D. ^{[5
,6
,7
]}

Havrdova, E. K. ^{[5
,6
,7
]}

Alroughani, R. ^{[8
]}

Izquierdo, G. ^{[9
]}

Eichau, S. ^{[9
]}

Ozakbas, S. ^{[10
]}

Butzkueven, H. ^{[11
,12
,13
]}

Patti, F. ^{[14
]}

Onofrj, M. ^{[15
]}

Lugaresi, A. ^{[16
,17
]}

Terzi, M. ^{[18
]}

Grammond, P. ^{[19
]}

Grand'Maison, F. ^{[20
]}

Yamout, B. ^{[21
]}

Prat, A. ^{[22
,23
,24
]}

Girard, M. ^{[22
,23
,24
]}

Duquette, P. ^{[22
,23
,24
]}

Boz, C. ^{[25
]}

Trojano, M. ^{[26
]}

McCombe, P. ^{[27
,28
]}

Slee, M. ^{[29
]}

Lechner-Scott, J. ^{[30
,31
]}

Turkoglu, R. ^{[32
]}

Sola, P. ^{[33
]}

Ferraro, D. ^{[33
]}

Granella, F. ^{[34
,35
]}

Shaygannejad, V. ^{[36
]}

Prevost, J. ^{[37
]}

Skibina, O. ^{[38
]}

Solaro, C. ^{[39
,40
]}

Karabudak, R. ^{[41
]}

Van Wijmeersch, B. ^{[42
,43
]}

Csepany, T. ^{[44
]}

Spitaleri, D. ^{[45
]}

Vucic, S. ^{[46
]}

Leray, E. ^{[3
]}

Sorensen, P. S. ^{[4
]}

Sellebjerg, F. ^{[4
]}

Magyari, M. ^{[4
]}

Vukusic, S. ^{[47
]}

Kalincik, T. ^{[14
]}

机构：

[1] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia

[2] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia

[3] EHESP Sch Publ Hlth, Dept Quantitat Methods Publ Hlth MeTIS, Rennes, France

[4] Univ Copenhagen, Danish Multiple Sclerosis Ctr, Dept Neurol, Rigshosp, Copenhagen, Denmark

[5] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic

[6] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic

[7] Gen Univ Hosp, Prague, Czech Republic

[8] Amiri Hosp, Dept Med, Div Neurol, Sharq, Kuwait

[9] Hosp Univ Virgen Macarena, Seville, Spain

[10] Dokuz Eylul Univ, Konak Izmir, Turkey

[11] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia

[12] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia

[13] Monash Univ, Box Hill Hosp, Dept Neurol, Melbourne, Vic, Australia

[14] Univ Catania, GF Ingrassia Dept, Policlin G Rodolico, Catania, Italy

[15] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy

[16] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy

[17] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

[18] 19 Mayis Univ, Fac Med, Samsun, Turkey

[19] CISSS Chaudiere Appalache, Levis, PQ, Canada

[20] Neuro Rive Sud, Quebec City, PQ, Canada

[21] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Med Ctr, Beirut, Lebanon

[22] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada

[23] CHUM, Montreal, PQ, Canada

[24] Univ Montreal, Montreal, PQ, Canada

[25] Farabi Hosp, KTU Med Fac, Trabzon, Turkey

[26] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy

[27] Univ Queensland, Brisbane, Qld, Australia

[28] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia

[29] Flinders Univ S Australia, Adelaide, SA, Australia

[30] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia

[31] Hunter New England Hlth, John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia

[32] Haydarpasa Numune Training & Res Hosp, Istanbul, Turkey

[33] Azienda Osped Univ, Dept Neurosci, Modena, Italy

[34] Univ Parma, Dept Med & Surg, Parma, Italy

[35] Parma Univ Hosp, Dept Emergency & Gen Med, Parma, Italy

[36] Isfahan Univ Med Sci, Esfahan, Iran

[37] CSSS St Jerome, St Jerome, PQ, Canada

[38] Monash Univ, Melbourne, Vic, Australia

[39] ASL3 Genovese, Dept Neurol, Genoa, Italy

[40] ML Novarese Hosp Moncrivello, Dept Rehabil, Genoa, Italy

[41] Hacettepe Univ, Ankara, Turkey

[42] Rehabil & MS Ctr Overpelt, Hasselt, Belgium

[43] Hasselt Univ, Hasselt, Belgium

[44] Univ Debrecen, Dept Neurol, Fac Med, Debrecen, Hungary

[45] Azienda Osped Rilievo Nazl San Giuseppe Moscati A, Avellino, Italy

[46] Westmead Hosp, Sydney, NSW, Australia

[47] Univ Hosp Lyon, Dept Neurol, Hop Pierre Wertheimer, Lyon, France

来源：

MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1418

引用

页码：786 / 788

页数：3

共 50 条

[1] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Cavit Boz
Serkan Ozakbas
Murat Terzi
Rana Karabudak
Serhan Sevim
Recai Turkoglu
Aysun Soysal
Belgin Petek Balcı
Hüsnü Efendi
Ömer Faruk Turan
Nur Yüceyar
Mehmet Fatih Yetkin
Serap Zengin Karahan
Meltem Demirkıran
Sibel Guler
Kadriye Agan
Nefati Kıylıoğlu
Cavid Baba
Asli Tuncer
Mesrure Köseoğlu
Neurological Sciences, 2023, 44 : 2121 - 2129
[2] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Boz, Cavit
Ozakbas, Serkan
Terzi, Murat
Karabudak, Rana
Sevim, Serhan
Turkoglu, Recai
Soysal, Aysun
Balci, Belgin Petek
Efendi, Husnu
Turan, Omer Faruk
Yuceyar, Nur
Yetkin, Mehmet Fatih
Karahan, Serap Zengin
Demirkiran, Meltem
Guler, Sibel
Agan, Kadriye
Kiylioglu, Nefati
Baba, Cavid
Tuncer, Asli
Koseoglu, Mesrure
NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
[3] Comparative effectiveness of natalizumab and fingolimod in subgroups of patients with relapsing-remitting multiple sclerosis from three international cohorts
Sharmin, Sifat
Lefort, Mathilde
Andersen, Johanna Balslev
Leray, Emmanuelle
Horakova, Dana
Havrdova, Eva
Alroughani, Raed
Ayuso, Guillermo Izquierdo
Ozakbas, Serkan
Patti, Francesco
Onofrj, Marco
Lugaresi, Alessandra
Terzi, Murat
Grammond, Pierre
Grand'Maison, Francois
Yamout, Bassem
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Boz, Cavit
Trojano, Maria
McCombe, Pamela
Slee, Mark
Lechner-Scott, Jeannette
Turkoglu, Recai
Sola, Patrizia
Ferraro, Diana
Granella, Franco
Prevost, Julie
Maimone, Davide
Skibina, Olga
Buzzard, Katherine
Van der Walt, Anneke
Van Wijmeersch, Bart
Csepany, Tunde
Spitaleri, Daniele Litterio A.
Vucic, Ostoja
Casey, Romain
Debouverie, Marc
Edan, Gilles
Ciron, Jonathan
Ruet, Aurelie
De Seze, Jerome
Maillart, Elisabeth
Zephir, Helene
Labauge, Pierre
Defer, Gilles
Lebrun-Frenay, Christine
Moreau, Thibault
Berger, Eric
NEUROLOGY, 2021, 96 (15)
[4] Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
Kalincik, T.
Horakova, D.
Spelman, T.
Jokubaitis, V.
Trojano, M.
Lugaresi, A.
Izquierdo, G.
Rozsa, C.
Grammond, P.
Alroughani, R.
Duquette, P.
Girard, M.
Pucci, E.
Lechner-Scott, J.
Slee, M.
Fernandez-Bolanos, R.
Grand'Maison, F.
Hupperts, R.
Verheul, F.
Hodgkinson, S.
Oreja-Guevara, C.
Spitaleri, D.
Barnett, M.
Terzi, M.
Bergamaschi, R.
McCombe, P.
Sanchez-Menoyo, J.
Simo, M.
Csepany, T.
Rum, G.
Boz, C.
Havrdova, E.
Butzkueven, H.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 195 - 196
[5] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles
Ozakbas, Serkan
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
Alroughani, Raed
Izquierdo, Guillermo
Eichau Madueno, Sara
Boz, Cavit
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Foschi, Matteo
Grand'Maison, Francois
John, Nevin
Grammond, Pierre
Terzi, Murat
Prevost, Julie
Barnett, Michael
Laureys, Guy
Van Hijfte, Liesbeth
Luis Sanchez, Jose
Blanco, Yolanda
Oh, Jiwon
Mccombe, Pamela
Ramo Tello, Cristina
Soysal, Aysun
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Yamout, Bassem I.
Khoury, Samia
Van Pesch, Vincent
Macdonell, Richard
Sa, Maria Jose
Slee, Mark
Kuhle, Jens
Maimone, Davide
Spitaleri, Daniele L. A.
Willekens, Barbara
Al-Asmi, Abdullah
Robertson, Neil
Coles, Alasdair
Brown, J. William L.
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 629 - 631
[6] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles
Ozakbas, Serkan
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
Alroughani, Raed
Eichau Madueno, Sara
Boz, Cavit
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Foschi, Matteo
Grand'Maison, Francois
John, Nevin
Grammond, Pierre
Terzi, Murat
Prevost, Julie
Barnett, Michael
Laureys, Guy
Van Hijfte, Liesbeth
Luis Sanchez-Menoyo, Jose
Blanco, Yolanda
Oh, Jiwon
Mccombe, Pamela
Ramo Tello, Cristina
Soysal, Aysun
Prat, Alexandre
Duquette, Pierre
Yamout, Bassem, I
Khoury, Samia
van Pesch, Vincent
Macdonell, Richard
Jose Sa, Maria
Slee, Mark
Kuhle, Jens
Maimone, Davide
Spitaleri, Daniele L. A.
Willekens, Barbara
Asmi, Abdallah Al
Tallantyre, Emma
Robertson, Neil P.
Coles, Alasdair
Brown, J. William
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : 1163 - 1175
[7] Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis
Kalincik, Tomas
Horakova, Dana
Spelman, Tim
Jokubaitis, Vilija
Trojano, Maria
Lugaresi, Alessandra
Izquierdo, Guillermo
Rozsa, Csilla
Grammond, Pierre
Alroughani, Raed
Duquette, Pierre
Girard, Marc
Pucci, Eugenio
Lechner-Scott, Jeannette
Slee, Mark
Fernandez-Bolanos, Ricardo
Grand'Maison, Francois
Hupperts, Raymond
Verheul, Freek
Hodgkinson, Suzanne
Oreja-Guevara, Celia
Spitaleri, Daniele
Barnett, Michael
Terzi, Murat
Bergamaschi, Roberto
McCombe, Pamela
Sanchez-Menoyo, Jose
Simo, Magdolna
Csepany, Tunde
Rum, Gabor
Boz, Cavit
Havrdova, Eva
Butzkueven, Helmut
ANNALS OF NEUROLOGY, 2015, 77 (03) : 425 - 435
[8] Comparison of the effectiveness of ocrelizumab vs interferons, fingolimod and natalizumab on relapses in relapsing-remitting multiple sclerosis
Roos, I.
Sharmin, S.
Ozakbas, S.
Horakova, D.
Havrdova, E. K.
Boz, C.
Alroughani, R.
Patti, F.
Terzi, M.
Lechner-Scott, J.
Izquierdo, G.
Eichau, S.
Grammond, P.
Buzzard, K.
Skibina, O.
Prat, A.
Girard, M.
Duquette, P.
Soysal, A.
Grand'Maison, F.
Kuhle, J.
van der Walt, A.
Butzkueven, H.
Turkoglu, R.
Butler, E.
Laureys, G.
van Hijfte, L.
Shaygannejad, V.
Yamout, B.
Khoury, S.
Prevost, J.
Sidhom, Y.
Gouider, R.
Cartechini, E.
Sanchez-Menoyo, J. L.
Sa, M. Jose
Macdonell, R.
van Pesch, V.
Ramo-Tello, C.
McCombe, P.
Willekens, B.
Spitaleri, D.
Ampapa, R.
Al-Asmi, A.
Slee, M.
Besora, S.
Malpas, C.
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 778 - 780
[9] Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia
Lasalvia, Pieralessandro
Hernandez, Fabian
Castaneda-Cardona, Camilo
Andres Cuestas, J.
Rosselli, Diego
VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 13 - 18
[10] Fingolimod for relapsing-remitting multiple sclerosis
La Mantia, Loredana
Tramacere, Irene
Firwana, Belal
Pacchetti, Ilaria
Palumbo, Roberto
Filippini, Graziella
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):

← 1 2 3 4 5 →